Christopher Posner

Christopher Posner

Chief Executive Officer en CARA THERAPEUTICS, INC. .

Fortuna: 164 274 $ al 31/03/2024

54 años
Health Technology
Consumer Services
Retail Trade

Perfil

Christopher A.
Posner
is currently the President, Chief Executive Officer & Director at CARA Therapeutics, Inc. Prior to his current position, he served as the President & Chief Executive Officer at Leo Pharma, Inc. from 2017 to 2021.
He also held the position of Head-Worldwide Commercial Operations at R-Pharm US LLC from 2014 to 2017.
Mr. Posner has an undergraduate degree from Villanova University and an MBA from The Fuqua School of Business.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
29/02/2024 180 521 ( 0.33% ) 164 274 $ 31/03/2024

Cargos activos de Christopher Posner

EmpresasCargoInicio
CARA THERAPEUTICS, INC. Chief Executive Officer 09/11/2021
Todos los cargos activos de Christopher Posner

Antiguos cargos conocidos de Christopher Posner.

EmpresasCargoFin
Chief Executive Officer 01/10/2021
Corporate Officer/Principal 01/01/2017
ZEVRA THERAPEUTICS, INC. Director/Board Member -
Ver el detalle de la experiencia de Christopher Posner.

Formación de Christopher Posner.

Villanova University Undergraduate Degree
The Fuqua School of Business Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Christopher Posner.

Relaciones

28

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
CARA THERAPEUTICS, INC.

Health Technology

ZEVRA THERAPEUTICS, INC.

Health Technology

Empresas privadas2

Retail Trade

Health Technology

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Christopher Posner